BIOABLATION
DEAD

Serial Number

88767438

Owner

MultiVir Inc.

Attorney

Adam S. Baldridge

Filing Date

Jan 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIOABLATION Trademark

Serial Number: 88767438

BIOABLATION is a trademark filed by MultiVir Inc. on January 21, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MultiVir Inc. (6 trademarks)

5100 Poplar Ave., Suite 805
Memphis, TN 38137

Entity Type: 03

Trademark Details

Filing Date

January 21, 2020

Registration Date

Not Registered

Goods & Services

Diagnostic and therapeutic biological therapy preparations for the treatment and destruction of tissue for medical treatment purposes

Biological preparations device for research, laboratory, pharmaceutical research, clinical, medical laboratory and manufacturing uses, in the field of medical therapeutics involving treatment and destruction of tissues by a biological therapeutic agent

Surgical and medical apparatus and instruments for medical use; medical apparatus and medical devices for the treatment of cancer or other hyperproliferative disorders; medical devices and instruments for use in surgical applications, interventional radiology, and therapeutic procedures for the treatment and destruction of tissue; cancer diagnosis apparatus; medical devices for performing biological therapy for targeted tissues; medical apparatus consisting of treatment probes and high pressure valves for delivering biological agents; mobile and portable stands and trolleys for medical devices; parts and fittings for all the aforesaid goods

Biological therapy-based pharmaceutical drug research and development in the field of biological therapeutics; development of biologic therapy-based pharmaceutical drugs and therapeutic compounds; development of biological drugs for the treatment of a wide variety of diseases and other conditions, namely, cancer and other hyperproliferative disorders; scientific and technological research services in the field of biological therapy; providing "in vitro" and "in vivo" preclinical and clinical testing of biological therapy products for scientific, research, healthcare, product development, consulting, and educational purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 2, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 2, 2020 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2020 NWOS
NEW APPLICATION ENTERED
Jan 24, 2020 NWAP